Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹4.89Admitted-Finance | ₹4.89 | L1 | Admitted-Finance |
| 2 | L2₹58.91+₹54.02 (1104.7%)Admitted-Finance RZ 132 B GALI NO 10 EAST SAGARPUR NEW DELHI SOUTH WEST DELHI DELHI 110046 | NEW DELHI | DELHI | 110046 | ₹58.91+₹54.02 (1104.7%) | L2 | Admitted-Finance |
| 3 | L3₹93.82+₹88.93 (1818.6%)Admitted-Finance | ₹93.82+₹88.93 (1818.6%) | L3 | Admitted-Finance |
| 4 | L4₹113.19+₹108.30 (2214.7%)Admitted-Finance | ₹113.19+₹108.30 (2214.7%) | L4 | Admitted-Finance |
| 5 | L5₹196.32+₹191.43 (3914.7%)Admitted-Finance | ₹196.32+₹191.43 (3914.7%) | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | MONU MEDICOS L2 | Supriya Medihealthcare Pvt. Ltd. L6 | CIRON DRUGS AND PHARMACEUTICALS PVT LTD L9 | CONCEPT BIOMEDICAL L7 | SMPL Life Sciences Pvt. Ltd. L10 | Prakash Medicos L11 | GOODLUCK PHARMACEUTICALS L5 | DPNR Medicals L1 | Verve Human Care Laboratories (A Unit of Venor Pharma Ltd.) L4 | SAZ ENTERPRISES L8 | RUSAN PHARMA LTD. L3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Dept of Main OT | ||||||||||||||
| 1.01 | Inj Ropivacaine 0.75% 4ml | 2,370 | VIAL | - | - | - | - | - | 69.3 ₹72.77 Lowest | - | - | - | - | - |
| 2.01 | Inj Cis-atracurium 2 mg/ml vial of 5 ml | 2,950 | VIAL | - | 140 ₹147 | 189 ₹198.45 | - | 115 ₹120.75 | 132 ₹138.6 | 49.56 ₹52.04 Lowest | - | - | 105 ₹110.25 | - |
| 3.01 | Lignocaine HCI solution 2% for IV use, 50 ml Inj | 925 | VIAL | - | - | - | 24.7 ₹25.93 | - | - | 23.4 ₹24.57 | - | - | 15 ₹15.75 Lowest | - |
| 4.01 | Neostigmine 0.5 mg, 1 ml Inj | 10,180 | AMP | 3.85 ₹4.04 Lowest | - | - | - | - | - | - | 4.66 ₹4.89 | - | 5.5 ₹5.78 | - |
| 5.01 | Inj Levobupivacaine vial 0.5% 20ml | 300 | VIAL | - | - | - | - | - | 113.3 ₹118.97 Lowest | - | - | - | - | - |
| 6.01 | Levobupicaine 0.5% inj in dextrose heavy | 770 | AMP | - | - | - | - | - | - | - | - | - | - | - |
| 7.01 | Inj Glycopyrrolate 0.5mg + Neostigmine 2.5mg | 2,700 | AMP | - | - | - | - | 18.75 ₹19.69 Lowest | 27.5 ₹28.88 | - | - | - | - | - |
| 8.01 | Ketamine HCI 50 mg/ml, 2 ml Inj | 6,050 | VIAL | - | - | 16.4 ₹17.22 | - | - | - | - | - | 16 ₹16.8 Lowest | - | - |
| 9.01 | Intralipid 20% in bottle of 100 ml | 160 | Bott | - | - | - | - | - | - | - | - | - | - | - |
Tender Value
₹17.0 L
EMD Value
₹84,799
Closing Date
6 Apr 2026, 6:00 pmClosed
THE COMMANDANT ARMY HOSPITAL R AND R
THE COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT
2433/MS/EXP/D 1034, 737/Main OT(Drugs)/IFA RE-150/2025-26 FOR AHRR
2026_ARMY_756466_1
2433/MS/EXP/D 1034, 737/Main OT(Drugs)/IFA RE-150/2025-26
Open Tender
Medical Equipments/Waste
Buy
ARMY HOSPITAL R AND R DELHI CANTT
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹84,799
Yes
6 Jun 2026
16 Mar 2026
7 Apr 2026
16 Mar 2026
6 Apr 2026
16 Mar 2026
16 Mar 2026 - 6 Apr 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Dept of Main OT | |||||
| 1.01 | Inj Ropivacaine 0.75% 4ml | 2,370 | VIAL | - | - |
| 2.01 | Inj Cis-atracurium 2 mg/ml vial of 5 ml | 2,950 | VIAL | - | - |
| 3.01 | Lignocaine HCI solution 2% for IV use, 50 ml Inj | 925 | VIAL | - | - |
| 4.01 | Neostigmine 0.5 mg, 1 ml Inj | 10,180 | AMP | - | - |
| 5.01 | Inj Levobupivacaine vial 0.5% 20ml | 300 | VIAL | - | - |
| 6.01 | Levobupicaine 0.5% inj in dextrose heavy | 770 | AMP | - | - |
| 7.01 | Inj Glycopyrrolate 0.5mg + Neostigmine 2.5mg | 2,700 | AMP | - | - |
| 8.01 | Ketamine HCI 50 mg/ml, 2 ml Inj | 6,050 | VIAL | - | - |
| 9.01 | Intralipid 20% in bottle of 100 ml | 160 | Bott | - | - |
stage.html
html • 0.05 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.58 MB
RFP.pdf
Tender Documents • 1.32 MB
BOQ_847342.xls
BOQ • 0.87 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .